Fernandez Sylvie, Rodier Jean-David, Ritter Nicolas, Mahler Bruno, Demarne Frédéric, Carrière Frédéric, Jannin Vincent
Laboratoire d'Enzymologie Interfaciale et de Physiologie de la Lipolyse, CNRS UPR 9025, Marseille, France.
Biochim Biophys Acta. 2008 Aug;1781(8):367-75. doi: 10.1016/j.bbalip.2008.05.006. Epub 2008 Jun 3.
Gelucire 44/14 is a semi-solid self-emulsifying excipient used for the oral delivery of poorly water-soluble drugs. It is composed of C8-C18 acylglycerols and PEG-32 esters, all of which are potential substrates for digestive lipases. Here we studied the lipolysis of Gelucire 44/14 by porcine pancreatic extracts, human pancreatic juice and several purified digestive lipases. Human pancreatic lipase (HPL), the main lipase involved in the digestion of triacylglycerols, did not show any significant activity on Gelucire 44/14 or on either of its individual compounds, C8-C18 acylglycerols and PEG-32 esters. Other pancreatic lipases such as human pancreatic lipase-related protein 2 (HPLRP2) showed low activity on Gelucire 44/14 although the highest activity of HPLRP2 was that observed on the C8-C18 acylglycerol fraction, which accounts for 20% (w/w) of Gelucire 44/14. In addition, HPLRP2 showed low activities on the PEG-32 esters, whether these were tested individually or mixed together. Carboxyl ester hydrolase (CEH) showed high activity on Gelucire 44/14, and the highest activities of CEH were those recorded on the total PEG-32 ester fraction and on each individual PEG-32 ester, except for PEG-32 monostearate. The highest activity of all the enzymes tested was that of dog gastric lipase (DGL) on Gelucire 44/14, although DGL showed low activity on the PEG-32 ester fraction and on each individual PEG-32 ester. We compared the lipolysis of Gelucire 44/14 with that of Labrasol, another self-emulsifying excipient, which is liquid at room temperature. Human pancreatic juice showed similar rates of activity on both Gelucire 44/14 and Labrasol. This finding means that these excipients are hydrolyzed in vivo during pancreatic digestion, mainly by CEH in the case of Gelucire 44/14 and by both HPLRP2 and CEH in that of Labrasol, whereas HPL showed very low activities on each of these two excipients. This is the first time the effects of PEG and acyl chain length on the lipolytic activity of digestive lipases on PEG esters have been investigated.
Gelucire 44/14是一种半固体自乳化辅料,用于口服递送难溶性药物。它由C8 - C18酰基甘油和PEG - 32酯组成,所有这些都是消化脂肪酶的潜在底物。在此,我们研究了猪胰腺提取物、人胰液和几种纯化的消化脂肪酶对Gelucire 44/14的脂解作用。人胰脂肪酶(HPL)是参与三酰甘油消化的主要脂肪酶,对Gelucire 44/14或其任何一种单独的化合物C8 - C18酰基甘油和PEG - 32酯均未表现出任何显著活性。其他胰腺脂肪酶,如人胰脂肪酶相关蛋白2(HPLRP2),对Gelucire 44/14表现出低活性,尽管HPLRP2的最高活性是在C8 - C18酰基甘油部分观察到的,该部分占Gelucire 44/14的20%(w/w)。此外,HPLRP2对PEG - 32酯表现出低活性,无论这些酯是单独测试还是混合在一起测试。羧基酯水解酶(CEH)对Gelucire 44/14表现出高活性,CEH的最高活性是在总PEG - 32酯部分以及除PEG -32单硬脂酸酯外的每种单独PEG - 32酯上记录到的值。所有测试酶中活性最高的是犬胃脂肪酶(DGL)对Gelucire44/14的活性,尽管DGL对PEG - 32酯部分以及每种单独的PEG - 32酯表现出低活性。我们将Gelucire 44/14的脂解作用与另一种自乳化辅料Labrasol(在室温下为液体)的脂解作用进行了比较。人胰液对Gelucire 44/14和Labrasol的活性速率相似。这一发现意味着这些辅料在胰腺消化过程中会在体内被水解,对于Gelucire 44/14主要由CEH水解,对于Labrasol则由HPLRP2和CEH共同水解,而HPL对这两种辅料中的任何一种都表现出非常低的活性。这是首次研究PEG和酰基链长度对消化脂肪酶对PEG酯脂解活性的影响